The Competition Commission of India, based on a positive prima facie determination on contravention of Section 4(2)(c) of the Competition Act, ordered investigation against pharma major Roche with respect to the cancer drug, Trastuzumab. The complaint was filed by Biocon and Mylan Pharmaceuticals. I shall be carrying a detailed analysis shortly. [Section 4. Abuse of Dominant position (1) No enterprise or group shall abuse its dominant position.] (2) There shall be an abuse of dominant position 4 [under sub-section (1), … Continue reading SpicyIP Tidbit: CCI Orders Investigation Against Pharma Major Roche